Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives
US5990117A · kind A · utility
30Cited by
42References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 1998 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Apr 15, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inhibiting neoplastic cells and related conditions by exposing them to substituted quinazoline compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.